After passing some regulations in 2024, Iowa state lawmakers are this year once again considering legislation that would further regulate pharmacy benefit managers — or PBMs.
The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
9don MSNOpinion
As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback